Efaproxiral Sodium: Properties, Mechanism & Lab Use Guide
Efaproxiral Sodium: Properties, Mechanism & Lab Use Guide
Efaproxiral Sodium is a synthetic allosteric modifier of hemoglobin designed to reduce hemoglobin–oxygen binding affinity and enhance oxygen delivery to hypoxic tissues, making it a valuable tool compound in preclinical hypoxia and oncology research.
- Chemical Name
- Efaproxiral Sodium (RSR13 sodium salt)
- Primary Mechanism
- Allosteric right-shift of the hemoglobin–oxygen dissociation curve, reducing O₂ binding affinity and increasing tissue O₂ delivery
- Research Applications
- Hypoxia biology, tumor microenvironment oxygenation, radiosentization studies, and oxygen transport modeling
- Solubility
- Soluble in water and aqueous buffers; sodium salt form improves aqueous solubility relative to free acid
- Storage Conditions
- Store at -20 °C, protected from light and moisture; verify conditions on CoA
- SKU
- E129487
Mechanism of Action
Efaproxiral Sodium (also known as RSR13) acts as a synthetic allosteric effector of hemoglobin. It binds within the central water cavity of the hemoglobin tetramer, stabilizing the deoxy (T-state) conformation. This stabilization reduces the overall affinity of hemoglobin for molecular oxygen, producing a rightward shift of the oxygen–hemoglobin dissociation curve (ODC). A right-shifted ODC means that, at a given partial pressure of oxygen (pO₂), hemoglobin releases a greater proportion of its oxygen cargo to surrounding tissues.
In tissues with low pO₂—such as hypoxic tumor cores or ischemic regions—this enhanced offloading can substantially increase oxygen availability. This property has been exploited in experimental oncology to sensitize poorly oxygenated tumors to radiation therapy, since molecular oxygen is required to fix radiation-induced DNA damage (the oxygen fixation hypothesis).
Importantly, Efaproxiral does not permanently modify hemoglobin; the interaction is reversible and concentration-dependent, which makes it suitable for controlled experimental dosing in in vitro and ex vivo systems.
Physicochemical Properties & Formulation
Efaproxiral Sodium is the sodium salt of efaproxiral (RSR13 free acid), a synthetic propanoic acid derivative. The sodium salt form confers superior aqueous solubility compared with the free acid, facilitating preparation of stock solutions in water or physiological buffers such as PBS.
Recommended stock solution preparation: Dissolve Efaproxiral Sodium in sterile ultrapure water or PBS (pH 7.4) to a concentration appropriate for your assay. Filter-sterilize (0.22 µm) if solutions are intended for cell-based experiments. Avoid prolonged exposure to strong light or oxidizing conditions. Prepare fresh working solutions or aliquot stocks and store at -20 °C to avoid repeated freeze–thaw cycles.
Compatibility: Verify compatibility with your specific assay buffer. Sodium salt solutions may shift buffer pH at high concentrations; adjust with dilute HCl or NaOH as needed and re-confirm pH before use.
Note: Always consult the product Certificate of Analysis (CoA) for lot-specific purity, molecular weight, and storage conditions before use.
Research Applications & Experimental Protocols
Efaproxiral Sodium is used in several experimental contexts:
- Tumor Oxygenation Studies: Added to red blood cell suspensions or whole-blood ex vivo systems to model enhanced oxygen delivery to hypoxic tumor compartments. Researchers measure changes in pO₂ profiles and correlate with cell viability or radiation sensitivity.
- Radiobiology: Used as a radiosensitizer tool compound in clonogenic survival assays. Cells or tissue slices are pre-incubated with Efaproxiral-treated erythrocytes before irradiation to assess improvement in oxygen enhancement ratio (OER).
- Oxygen–Hemoglobin Dissociation Curve (ODC) Assays: Efaproxiral Sodium is added at graded concentrations to hemoglobin or blood preparations, and ODC is measured using a Hemox Analyzer or equivalent instrument to quantify the P₅₀ shift.
- Hypoxia Model Validation: Employed as a positive control or reference agent in in vitro hypoxia models to confirm that altered oxygenation produces expected biological outcomes (e.g., HIF-1α modulation).
General Protocol Guidance: Determine the working concentration empirically for each assay system. Negative (vehicle) and positive controls should always be included. Record lot number, storage history, and reconstitution details for reproducibility.
Safety, Handling & Regulatory Considerations
Efaproxiral Sodium is supplied as a research-use-only reagent and is not approved for therapeutic use in humans. Standard laboratory safety precautions apply:
- Wear appropriate personal protective equipment (PPE): laboratory coat, nitrile gloves, and eye protection when handling powders or concentrated solutions.
- Handle powder forms in a well-ventilated area or fume hood to avoid inhalation of fine particles.
- Dispose of waste in accordance with your institution's chemical waste disposal regulations.
- Refer to the Safety Data Sheet (SDS) provided by Aladdin Scientific for complete hazard classifications, first-aid measures, and disposal guidelines specific to this product.
Stability: The compound is stable under recommended storage conditions (-20 °C, dry, protected from light). Degradation may occur with repeated freeze–thaw cycling or exposure to moisture and light; monitor purity by HPLC if stability is critical for your assay.
Researchers are responsible for complying with all applicable institutional, national, and international regulations when using this compound.
Frequently asked questions
What is Efaproxiral Sodium used for in research?
Efaproxiral Sodium is primarily used as an allosteric hemoglobin modifier in preclinical research to study enhanced oxygen delivery to hypoxic tissues, including hypoxic tumor microenvironments. It is also employed as a tool compound in radiobiology to investigate radiosensitization mechanisms and in assays measuring shifts in the oxygen–hemoglobin dissociation curve.
How should I prepare a stock solution of Efaproxiral Sodium?
Dissolve Efaproxiral Sodium in sterile ultrapure water or PBS (pH 7.4) to the desired concentration. Filter-sterilize through a 0.22 µm membrane if the solution will be used in cell-based assays. Aliquot and store at -20 °C protected from light, and avoid repeated freeze–thaw cycles. Always consult the lot-specific Certificate of Analysis for confirmed purity and molecular weight before calculating your working concentration.
Is Efaproxiral Sodium suitable for in vivo studies?
Efaproxiral Sodium is supplied by Aladdin Scientific for research use only and is not approved for clinical or therapeutic administration. Its suitability for in vivo preclinical animal studies depends on institutional ethics approval, appropriate formulation development, and compliance with all relevant regulations. Researchers intending in vivo use should consult their institutional animal care and use committee (IACUC) and review the literature for established dosing protocols.
How does Efaproxiral Sodium differ from 2,3-DPG in modulating hemoglobin oxygen affinity?
Both Efaproxiral and 2,3-diphosphoglycerate (2,3-DPG) reduce hemoglobin oxygen affinity by stabilizing the T-state (deoxy) conformation, resulting in a rightward shift of the ODC. However, 2,3-DPG is an endogenous allosteric regulator produced during glycolysis, whereas Efaproxiral is a synthetic small-molecule effector that binds a similar but distinct site, allowing researchers to modulate hemoglobin oxygen affinity independently of cellular metabolic state in experimental systems.
References
- Aladdin Scientific Product Information: Efaproxiral Sodium, SKU E129487. Aladdin Scientific, Shanghai.
- Aladdin Scientific Safety Data Sheet: Efaproxiral Sodium. Consult current SDS for hazard classification and handling guidance.
- General reference: Allosteric modifiers of hemoglobin and the oxygen-hemoglobin dissociation curve — textbook-level concept. Specific published studies on RSR13/efaproxiral should be identified and cited by the reviewer.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证（带存储）